Collegium Pharmaceutical, Inc. Common Stock
Symbol: COLL (NASDAQ)
35.89
▲ (0.50%) 0.178
Company Description:
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
Key Stats
- Today's Open: $35.6
- Today's High: $36.06
- Today's Low: $35.07
- Today's Volume: 48.87K
- Yesterday Close: $35.71
- Yesterday High: $35.915
- Yesterday Low: $35.13
- Yesterday Volume: 321.96K
- Last Min Volume: 2
- Last Min High: $35.9
- Last Min Low: $35.9
- Last Min VWAP: $35.9
Company Profile
- Name: Collegium Pharmaceutical, Inc. Common Stock
- Website: https://www.collegiumpharma.com
- Listed Date: 2015-05-07
- Location: STOUGHTON, MA
- Market Status: Active
- CIK Number: 0001267565
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.11B
- Round Lot: 100
- Outstanding Shares: 31.50M
- Asset Type: CS
RECENT FILINGS FOR COLL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 4 | View |
| 2025-08-29 | 144 | View |
| 2025-08-20 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 3 | View |
| 2025-08-15 | 144 | View |
| 2025-08-13 | 144 | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-12 | 4 | View |
| 2025-08-11 | SCHEDULE 13G/A | View |
| 2025-08-07 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-09 | 144 | View |
| 2025-07-08 | 144 | View |
| 2025-07-07 | 144 | View |
| 2025-07-07 | 8-K | View |